Lv3
384 积分 2023-05-12 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1天前
已完结
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial
1天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
1天前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
3天前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial
3天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
14天前
已完结
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial
17天前
已完结
Metastasis prevention with bone-targeted agents: a complex interaction between the microenvironment and tumour biology
24天前
已完结
Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy‐proven node‐positive breast cancer: A prospective study
3个月前
已完结
The predictive value of DKI in breast cancer: Does tumour subtype affect pathological response evaluations?
3个月前
已完结
皖公网安备34019202002308
